Company News, News Releases Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study
Company News, News Releases Sona Nanotech to Showcase its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update
Company News, News Releases Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds
Company News, News Releases Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing
Company News, News Releases Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
Company News, News Releases Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent
Company News, News Releases Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model
Company News, News Releases Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
Company News, News Releases Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing